Diabetes. Diabetes mellitus due to underlying condition with hyperosmolarity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Registration of Type II Diabetes Mellitus in the medical records of the Diabetes Clinic 2.Lack of injecting insulin. 3.Having informed consent to participate in the study. 4.Not having a history of mental illness 5.Do not use herbal remedies that affect blood sugar levels. 6.Do Not Advanced Neuropathy. 7.Lack of history of physical illness simultaneously 8. At least one year of diabetes 9.Lack of alcohol and drug use 10. between 50-20 years 11.Minimum cycle education 12. Non-use of psychotropic drugs and cognitive therapies during the study 13.Non-attendance at yoga classes, meditation, pacifism, special sports activities, lifestyle and adaptation strategies in the past six months 14.Lack of hearing and speech problems 15.Patients undergoing treatment and without changes to the drug during the study period 16.Iranian nationality 17.No incident in the last 6 months 18.Do not use corticosteroids drugs
Exclusion criteria
Exclusion criteria: 1.It is not participating in training classes 2.Dissatisfaction with continued collaboration during the study period 3.Depending on other endocrine disorders 4.Cancel the continuation of participation in the workshop 5.Changes in the general condition of the patient associated with changes in blood glucose levels 6.ComplicationsSevere diabetes mellitus 7.Not participating in two training sessions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Study of Depression. Timepoint: Check the variables before, immediately after and three months after the intervention. Method of measurement: DASS21 questionnaire.;Check the amount of stress. Timepoint: Before intervention immediately after intervention, and three months after intervention. Method of measurement: DASS21 questionnaire.;Anxiety Survey. Timepoint: Before intervention immediately after intervention, and three months after intervention. Method of measurement: DASS21 questionnaire.;Study of HBA1c. Timepoint: Before intervention immediately after intervention, and three months after intervention. Method of measurement: blood test.;Cortisol levels. Timepoint: Before intervention immediately after intervention, and three months after intervention. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Rafsanjan University of Medical Sciences